CA184169A - Pompe - Google Patents

Pompe

Info

Publication number
CA184169A
CA184169A CA000184169A CA184169DA CA184169A CA 184169 A CA184169 A CA 184169A CA 000184169 A CA000184169 A CA 000184169A CA 184169D A CA184169D A CA 184169DA CA 184169 A CA184169 A CA 184169A
Authority
CA
Canada
Prior art keywords
pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000184169A
Other languages
English (en)
Inventor
Caleb Roach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA184169A publication Critical patent/CA184169A/fr
Expired legal-status Critical Current

Links

CA000184169A 1917-05-03 1917-05-03 Pompe Expired CA184169A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA184169T 1917-05-03

Publications (1)

Publication Number Publication Date
CA184169A true CA184169A (fr) 1918-05-07

Family

ID=45303821

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000184169A Expired CA184169A (fr) 1917-05-03 1917-05-03 Pompe

Country Status (1)

Country Link
CA (1) CA184169A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022098952A1 (fr) 2020-11-06 2022-05-12 Bristol-Myers Squibb Company Dosage et administration d'anticorps anti-ctla-4 non fucosylé en tant que monothérapie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022098952A1 (fr) 2020-11-06 2022-05-12 Bristol-Myers Squibb Company Dosage et administration d'anticorps anti-ctla-4 non fucosylé en tant que monothérapie

Similar Documents

Publication Publication Date Title
CA182145A (fr) Forme
CA184169A (fr) Pompe
CA183209A (fr) Pompe
CA183203A (fr) Pompe
CA179983A (fr) Pompe
CA185715A (fr) Pompe
CA175620A (fr) Pompe
CA176242A (fr) Pompe
CA176662A (fr) Pompe
CA176740A (fr) Pompe
CA178775A (fr) Pompe
CA178814A (fr) Pompe
CA178817A (fr) Pompe
CA178819A (fr) Pompe
CA178829A (fr) Pompe
CA183508A (fr) Pompe
CA180424A (fr) Pompe
CA180435A (fr) Pompe
CA180485A (fr) Pompe
CA181110A (fr) Pompe
CA182120A (fr) Pompe
CA182122A (fr) Pompe
CA182280A (fr) Pompe
CA183146A (fr) Pompe
CA184701A (fr) Pompe